Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
New technologies and strategies for fuel cells and hydrogen technologies in the phase of recycling and dismantling (HYTECHCYCLING)

Framework: Horizon 2020 — Societal Challenges
Programme: Smart, green and integrated transport
Theme: Public-private partnerships
Destination: Fuel Cells and Hydrogen
Action type: Coordination and support actions
Partnership: FCH2 (Art-187)
Countries involved: Spain,Italy,Spain,Spain,Slovenia
Call: Recycling and Dismantling Strategies for FCH Technologies (H2020-JTI-FCH-2015-1, 2015)
Start date: 2016-05-01
End date: 2019-04-30
Duration (months): 36.0
Total project cost (EUR): 497666.25
EU funding (EUR): 497666.25
Participants: 5
Project status: CLOSED

High deployment of fuel cells and hydrogen technologies is expected in the near term in the EU to decarbonize energy and transport sectors. The idea is to generate vast amounts of green hydrogen from the expected surplus of renewable energy sources (implemented policies are going towards 65% of electricity from renewable energy sources by 2050) to be used in transport (moving fuel cell electric vehicles), energy (feeding stationary fuel cells for cogeneration, injecting hydrogen into the gas grid) and industries (hydrogen generation for chemical industries). However, the expected commercial FCH technologies (mainly PEM and alkaline electrolysers as well as PEM and Solid Oxide fuel cells) are not prepared for full deployment in what regards to recycling and dismantling stage. The main goal of proposal is to deliver reference documentation and studies about existing and new recycling and dismantling technologies and strategies applied to Fuel Cells and Hydrogen (FCH) technologies, paving the way for future demonstration actions and advances in legislation. To achieve this goal, the following key steps will be followed considering the involvement and validation of relevant FCH value chain actors and the HYTECHCYCLING Advisory Board of manufacturers: 1. Pre-study and techno-economic, environmental, RCS assessment related to dismantling & recycling of FCH technologies to detect future needs and challenges 2. Development of new technologies and strategies applied to FCH technologies in the phase of recycling & dismantling and LCA analysis considering critical, expensive and scarce materials inventory 3. Proposal of new business model, implementation roadmap and development of reference recommendations and guidelines to focus the sector and pave the way for future demonstrations and introduction of the concept among FCH stakeholders

Keywords: electrolysers,recycling,dismantling,end of life,reuse,remanufacturing
Recessions, labour-market uncertainty and health (RecessionsHealth)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Economic Sciences
Countries involved: Netherlands
Call: Marie Skłodowska-Curie Individual Fellowships (IF-EF) (H2020-MSCA-IF-2015, 2015)
Start date: 2016-03-01
End date: 2018-02-28
Duration (months): 24.0
Total project cost (EUR): 165598.8
EU funding (EUR): 165598.8
Participants: 1
Project status: CLOSED

My postdoctoral project for the Marie-Sklodowska-Curie fellowship deals with recessions and health. The aim of the proposal is to provide a comprehensive analysis of how individual health is affected (both in the short and in the long-run) when recessions cause uncertainty on the labour-market. To achieve this aim, I will exploit two major recessions – the 2008 Great Recession and the 1990s Swedish recession – as well as particularly rich administrative data to answer two well-posed and policy-relevant questions: (1) Do individuals who experience major labour-market uncertainty during by recessions suffer from health disorders in the short-run? (2) Do recessions at career entry negatively affect health over the life-course – and in particular in the long-run? To adress these questions, the proposal will tackle two related and complementary specific objectives: (1) Analyse the short-term consequences of the drastic cuts in art subsidies in the Netherlands in the wake of the 2008 Great Recession – which triggered major labour market uncertainty in the art sector – on health outcomes for individuals in the art sector. (2) Investigate the long-run health effects of graduating in the 1990s Swedish Great recession using an innovative life-course perspective. Both the framework and the methodology used in these two projects are challenging and new. First, I exploit natural experiments as exogenous shocks on labour-market conditions, which allows deriving causal estimates. Second, I use particularly rich linked administrative data over long periods of time, which enables me to take a life-course perspective. I strongly believe that this unprecedented combination of the original concepts, the methodology, that is completely new to the field, and my particularly large and rich datasets will provide a completely new avenue to understand how individual health responding to labour-market uncertainty caused by recessions is affected, both in the short and long-run.

Keywords: health economics
Quantum Kinetic Equations for Pre-thermal Light and Matter (QUAKE4PRELIMAT)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Global Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Physics
Countries involved: Switzerland,United States
Call: Individual Fellowships (H2020-MSCA-IF-2016, 2016)
Start date: 2018-03-01
End date: 2021-02-28
Duration (months): 36.0
Total project cost (EUR): 265840.2
EU funding (EUR): 265840.2
Participants: 2
Project status: CLOSED

One of the research forefronts in quantum many body physics, is represented by the non-equilibrium dynamics of strongly interacting photons coupled to quantum matter. However, while tools to deal with quantum optics systems of few constituents are available, many particle effects require the development of advanced and timely methods. The QUAKE4PRELIMAT project will: (i) provide a new technique to confront with the dynamical evolution of a many body photon system coupled to an ensemble of atoms, exporting the quantum kinetic equation method (based on the two-particle irreducible effective action) from the domain of high energy physics; (ii) look for the onset of pre-thermal non-equilibrium states in quantum optics systems, where light and matter equilibrate at different temperatures; (iii) extend concepts tailored for pre-thermalization in isolated systems, as the Luttinger Liquid model and the Generalized Gibbs Ensemble, to driven open low dimensional quantum many body systems; under the supervision of two world renowned experts on strongly correlated physics, in Harvard and Geneva. The outcomes of this research project will pave the way to pre-thermalization in driven open systems, with a multitude of applications, and will provide to the quantum optics and condensed matter communities, the (previously lacking) tools to handle the dynamics of many body photon systems. The European Union will make a step forward in a field with tantalizing technological perspectives, as photon logic gates, quantum computing based on interacting photons, molecules and crystals of quantum light. A number of outreach activities are planned to increase the awareness of the general public on such potentialities. Finally, the experienced researcher will learn how to apply his theoretical background to concrete physical platforms, will grow in scientific leadership, will learn how to drive a new research trend into the condensed matter and quantum optics areas.

Keywords: out of equilibrium many body quantum optics,quantum kinetic equations,pre thermalization,quantum quenches,driven open systems,strongly correlated systems in one dimension
Regulation and reprogramming of alternative splicing in cellular transformation (SPLICANCER)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Life Sciences
Countries involved: Italy
Call: Individual Fellowships (H2020-MSCA-IF-2016, 2016)
Start date: 2017-07-01
End date: 2019-06-30
Duration (months): 24.0
Total project cost (EUR): 168277.2
EU funding (EUR): 168277.2
Participants: 1
Project status: CLOSED

Alternative splicing (AS), by affecting nearly 90 percent of human genes, is the major contributor to protein diversity. Mutations that disrupt AS regulatory sequences are a widespread source of human diseases. Various evidences suggest that an AS reprogramming is critical in cell adaptation during cancer development. In spite of increasing interest in the potential oncogenic role of AS, little is known about the molecular mechanisms behind its deregulation during the somatic to the cancer cell transformation. Our aim is to contribute to the characterisation of AS reprogramming during the somatic to the proliferative cancer cell transformation using myosin VI as model system. Recent studies from the host lab reported how myosin VI AS modulates its interactome leading to different cellular functions (endocytosis for the long isoform and cell migration for the short one). The lab found that alternative myosin VI splicing is aberrantly regulated in cancer, where exon skipping dictates cell addiction to myosin VIshort for tumour cell migration.In this proposal, we intends to 1) Identify the myosin VI’s alternative splicing regulators and define their role in vitro, 2) identify common splicing-regulated events that occur during the establishment of a fully polarized epithelial architecture and that are possibly deregulated in cancer (AS reprogramming), 3) assess whether cancer stem cells express a specific set of the identified AS genes.Preliminary results revealed that myosin VI isoforms expression can be switch on/off in selective culture conditions. We will take advantage of this beahviour to set up our analysis based on a multidisciplinary approach that includes biochemical, mass spectrometry and cellular biological assayes. The new set of information will gained with this proposal will be instrumental to understanding the molecular mechanism at the basis of AS (de)regulation for myosin VI and more in general for cell transformation during cancer progression.

Keywords: alternative splicing,rna binding proteins,cell migration,cell polarization,oncogenic mechanisms
Diagrammatic Quantum Computation (DQC)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: United Kingdom
Call: Individual Fellowships (H2020-MSCA-IF-2020, 2020)
Start date: 2022-09-01
End date: 2024-08-31
Duration (months): 24.0
Total project cost (EUR): 212933.76
EU funding (EUR): 212933.76
Participants: 1
Project status: CLOSED

Existing quantum computers are on the verge of solving practical problems that are intractable for classical computers. The obstacles that are holding current generation quantum computers back are their limited number of qubits and the presence of noise, both of which prohibit lengthy computations. Tools that decrease the size of a given computation can hence greatly increase the scope of problems current quantum computers can solve. This project will build such tools. Firstly, we develop new methods and software for optimising quantum circuits. Secondly, we build powerful verification methods that ensure correctness of our optimisations. Thirdly, we develop classical simulators of quantum circuits to allow the testing of quantum computations. While these might seem like disparate problems, in our approach they become aspects of a single problem which is solved by employing powerful graph-theoretic simplification methods that combine techniques from measurement-based quantum computation, tensor networks and the ZX-calculus. This allows us to develop simplifications that would be hard to find with previous methods. In summary, this project unifies the problems of optimisation, verification and simulation of quantum circuits while improving upon the state-of-the-art.

Keywords: quantum software
Innovative new technology for creating value from mixed waste plastic (mixedplasticvalue)

Framework: Horizon 2020 — Societal Challenges
Programme: Climate action, environment,  resource efficiency and raw materials
Action type: SME instrument
Countries involved: United Kingdom
Call: Boosting the potential of small businesses for eco-innovation and a sustainable supply of raw materials (H2020-SMEINST-1-2015, 2015)
Start date: 2015-07-01
End date: 2015-12-31
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Impact Laboratories Ltd have developed a method for the cost efficient separation of mixed polymers, using a patent pending process of vertically arranged blades oscillating to produce separation. Unlike current separation methods, the process is capable of working in an uncontrolled density solution of water for all polymers and is significantly less than 50% of the Capital and Operational cost of existing technology, while exceeding the quality requirements of the industry. This technology has the potential to revolutionize plastic recycling across Europe and funding will help us bring it to market quicker. Developed to meet the needs of the recyclers, the process involves a low capital and operational expenditure, which opens the equipment to small and medium sized recyclers across Europe, allowing them to separate plastics which are currently classed as too expensive to separate. This adds value to the recycler, and provides manufacturers a rich source of useable recycled material at a local level. Our technology has the potential to make a major change in the way plastics are recycled across Europe. Every unit will reduce plastic to landfill by 2000/tonnes a year, helping Europe meet the EU goals for plastic recycling by 2020. Just 50 units operating across Europe will reduce the plastic going to landfill by one percent and create thousands of jobs throughout Europe in recycling, supply chain and manufacturing. Phase 1 will see Impact Laboratories undertake a feasibility assessment for introducing the technology across the European market. We will look at the supply chains, the needs of recyclers from different European countries and the needs of manufacturers throughout Europe to ensure the technology addresses their needs. Impact Laboratories will look to role the technology out by franchise or licence in phase 2, to allow European recyclers to reduce the plastic going to landfill.

Keywords: plastic separation technology
A co-operative mHEALTH environment targeting adherence and management of patients suffering from Heart Failure (HEARTEN)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Active ageing and self-management of health
Action type: Research and Innovation actions
Countries involved: Germany,Italy,Spain,Italy,Spain,Italy,Greece,Greece,France,Portugal
Call: Self management of health and disease: citizen engagement and mHealth (H2020-PHC-2014-single-stage, 2014)
Start date: 2015-01-01
End date: 2018-03-31
Duration (months): 39.0
Total project cost (EUR): 4589507.49
EU funding (EUR): 4589507.0
Participants: 15
Project status: CLOSED

HEARTEN will design, develop and validate an ICT co-operative environment that will enable the HF patients to achieve sustainable behavior change regarding their adherence and compliance, and the ecosystem actors to be engaged and improve the patients’ HF management. HEARTEN targets all actors related to the management of patients suffering from HF, including healthcare professionals, caregivers (formal/informal), healthcare providers nutritionists, fitness experts and health insurance experts, towards developing a multi-stakeholder patient centered mHealth ecosystem. The target population of HEARTEN are patients with chronic and acute HF, either post-ischemic or with dilated cardiomyopathy, requiring occasionally re-admittance into hospitals. The idea is to develop biosensors that detect and quantify novel breath and saliva HF biomarkers, being identified through analytical techniques. These biomarkers reflect the health status of the patient and identify whether the patient adheres to the administered drugs. The breath biosensor will be integrated into the smartphone while the saliva biosensor will be integrated into the patient’s cup. Additional sensors for monitoring the ECG, the blood pressure and the physical activity constitute the sensor kit of the patient. The input data are complemented with nutrition information from the patient’s smartphone, weight monitoring through wireless weight scales as well as the patient’s profile and information directly added by the caregivers and the healthcare professionals. The multiparametric data are transmitted to the HEARTEN cloud architecture, where a knowledge management system analyses them and delivers critical information at hand. HF patients are empowered in self-management, by using their smartphones and tracking their medical vital signs, while the healthcare professionals and the caregivers can issue warnings, coordinate therapies, improve adherence and intervene before frailty incidences occur.

Keywords: patient empowerment,drug adherence,biosensors,heart failure,ict cooperative environment
Categorical Interoception Project: How generalization and classification strategies link anxiety and interoception (CIP)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: Luxembourg
Call: Marie Skłodowska-Curie Individual Fellowships (IF-EF) (H2020-MSCA-IF-2014, 2014)
Start date: 2016-04-01
End date: 2018-03-31
Duration (months): 24.0
Total project cost (EUR): 172800.0
EU funding (EUR): 172800.0
Participants: 1
Project status: CLOSED

Bias in the perception of bodily sensations (interoception) can be dangerous or even fatal; for example, if we do not recognize signs of a stroke or take medication anytime we feel the slightest change in our body. Research consistently reports that anxiety is closely related to interoception and (mis)interpretation of bodily sensations, but little is known about more fundamental processes underlying this relationship. The aim of this project is to test whether categorization as basic perceptual process links anxiety and interoception via generalization and perceptual decision strategies. Bundling the continuous flow of interoceptive information into distinct categories such as “pain” or “pleasure” can facilitate perception and coping. By assigning sensations to interoceptive categories (e.g., symptom groups) we can infer information about causes and consequences and apply coping schemata fast and efficiently. Research on visual perception, however, suggests that anxiety can be related to excessive generalization which may turn into harmful over-generalization, particularly if stimuli are misclassified. We will test whether also in interoception, anxiety is related to excessive category-related generalization. Furthermore, we will test whether individuals higher in anxiety are more prone to take a “better safe than sorry” strategy and misclassify benign sensations (e.g., heartbeat and breathlessness associated with exercise) more often as sign of disease. We will test our hypotheses of categorization linking anxiety and interoception in a newly developed research paradigm. In contrast to traditional paradigms, it allows distinguishing interoceptive accuracy and bias. The project is of theoretical relevance by targeting fundamental processes linking anxiety and interoception. Furthermore, it is of clinical relevance by testing the relationship between anxiety and interoceptive classification strategies, which are related to choices in health behaviour.

Keywords: categorization,interoception,anxiety,anxiety sensitivity
ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences. (ELIXIR-EXCELERATE)

Framework: Horizon 2020 — Excellent Science
Programme: Research Infrastructures
Theme: Research infrastructures
Destination: Development and infrastructures
Action type: Research and Innovation actions
Countries involved: Spain,Spain,Estonia,Israel,Spain,Spain,Spain,Italy,Germany,Finland,Norway,Norway,Norway,Norway,Slovenia,Sweden,Sweden,Sweden,Switzerland,Belgium,Greece,Greece,Greece,France,Czechia,Czechia,Netherlands,Netherlands,Netherlands,Netherlands,Netherlands,Netherlands,Denmark,Denmark,Denmark,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,Portugal,Portugal
Call: Individual implementation and operation of ESFRI projects (H2020-INFRADEV-1-2015-1, 2015)
Start date: 2015-09-01
End date: 2019-08-31
Duration (months): 48.0
Total project cost (EUR): 19051482.0
EU funding (EUR): 19051482.0
Participants: 60
Project status: CLOSED

The life sciences are undergoing a transformation. Modern experimental tools study the molecules, reactions, and organisation of life in unprecedented detail. The precipitous drop in costs for high-throughput biology has enabled European research laboratories to produce an ever-increasing amount of data. Life scientists are rapidly generating the most complex and heterogeneous datasets that science can currently imagine, with unprecedented volumes of biological data to manage. Data will only generate long-term value if it is Findable, Accessible, Interoperable and Re-usable (FAIR). This requires a scalable infrastructure that connects local, national and European efforts and provides standards, tools and training for data stewardship. Formally established as a legal entity in January 2014, ELIXIR - the European life science Infrastructure for Biological Information - is a distributed organisation comprising national bioinformatics research infrastructures and the European Bioinformatics Institute (EMBL-EBI). This coordinated infrastructure includes data standards, exchange, interoperability, storage, security and training. Recognising the importance of a data foundation for European life sciences, the ESFRI and European Council named ELIXIR as one of Europe’s priority Research Infrastructures. In response ELIXIR have developed ELIXIR-EXCELERATE. The project will fast-track ELIXIR’s early implementation phase by i) coordinate and enhance existing resources into a world-leading data service for academia and industry, ii) grow bioinformatics capacity and competence across Europe, and iii) complete the management processes needed for a large distributed infrastructure. ELIXIR-EXCELERATE will deliver a step-change in the life sciences. It will enable cost-effective and sustainable management and re-use of data for millions of users across the globe and improve the competitiveness of European life science industries through accessible data and robust standards and tools.

Keywords: research infrastructures,bioinformatics,life science data,health,agriculture,sustainable data management,biotechnology,biomedical